Quadrant Capital Group’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
Other funds holding MLAB
LPP
RIM
Quadrant Capital Group's MLAB Position: Q2 2026 in Review
Quadrant Capital Group sold out of Mesa Laboratories (MLAB) in Q2 2026, closing a stake of 5 shares — an estimated $443 sold.
Quadrant Capital Group first reported a position in MLAB in Q1 2020 and held it in 21 quarters. The position peaked at $48.9K in Q1 2023. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.
- Quadrant Capital Group reported no remaining Mesa Laboratories position as of Q2 2026 after selling out during the quarter.
- Quadrant Capital Group sold 5 Mesa Laboratories shares in Q2 2026, an estimated $443.
- Quadrant Capital Group first reported a position in Mesa Laboratories in Q1 2020 and held it in 21 quarters.
- Quadrant Capital Group's Mesa Laboratories position peaked at $48.9K in Q1 2023.
- 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.